Network science in clinical trials: A patient-centered approach

Area of Science:

• Oncology
• Systems Biology
• Bioinformatics

Background:

• The integration of novel molecular diagnostic tools in translational oncology presents significant challenges.
• High-throughput omics profiling generates vast datasets requiring sophisticated analysis beyond linear modeling.
• Current analytical methods may limit a comprehensive understanding of cancer as a complex disease.

Purpose of the Study:

• To address the challenges in integrating advanced molecular diagnostics into clinical oncology.
• To propose network science and systems biology approaches for analyzing complex cancer data.
• To develop a framework for implementing network science in clinical trial designs for precision medicine.

Main Methods:

• Reviewing challenges associated with high-throughput molecular profiling in cancer.
• Applying network science and machine learning principles to integrate multi-omics data.
• Developing a framework for novel clinical trial designs incorporating network science.

Main Results:

• Network science and systems biology approaches can uncover complex biological changes by integrating multiple data sources.
• These integrated approaches can identify a larger number of potential biomarkers for therapeutic decision-making.
• A new generation of clinical trials is necessary to fully leverage these advanced analytical methods.

Conclusions:

• Network science offers a powerful framework to advance cancer care by enabling a deeper understanding of cancer complexity.
• Implementing network science in clinical trials is crucial for making substantial progress towards precision medicine.
• This approach promises to improve therapeutic decisions and patient outcomes in oncology.